Literature DB >> 8876675

Base analog N6-hydroxylaminopurine mutagenesis in Escherichia coli: genetic control and molecular specificity.

Y I Pavlov1, V V Suslov, P V Shcherbakova, T A Kunkel, A Ono, A Matsuda, R M Schaaper.   

Abstract

We have studied the molecular specificity of the base analog N6-hydroxylaminopurine (HAP) in the E. coli lacI gene, as well as the effects of mutations in DNA repair and replication genes on HAP mutagenesis. HAP induced base substitutions of the two transition types (A . T-->G . C and G . C-->A . T) at equal frequency. This bi-directional transition specificity is consistent with in vitro primer extension experiments with the Klenow fragment of DNA polymerase I in which we observed that either dTTP or dCTP were incorporated opposite HAP in an oligonucleotide template. The spectrum of HAP-induced transitions was different from the spontaneous transitions in either a wild-type or a mismatch-repair-defective (mutL) strain. Mutations in genes controlling excision repair, exonucleolytic proofreading, mismatch correction, error-prone (SOS) repair and 8-oxo-guanine repair did not affect HAP-induced mutagenesis substantially. However, an extensive deletion of several genes in the uvrB-bio region conferred supersensitivity to the lethal and mutagenic effects of HAP, perhaps due to an effect on HAP metabolism. dnaE antimutator alleles reduced HAP-forward mutagenicity in allele-specific manner: dnaE911 reduced it several fold, while dnaE915 abolished it almost completely. The results obtained are consistent with the idea that HAP is mutagenic in E. coli via a pathway generating replication errors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876675     DOI: 10.1016/0027-5107(96)00060-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  16 in total

1.  Genetic requirements and mutational specificity of the Escherichia coli SOS mutator activity.

Authors:  I J Fijalkowska; R L Dunn; R M Schaaper
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

Review 2.  Antimutator mutants in bacteriophage T4 and Escherichia coli.

Authors:  R M Schaaper
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

3.  Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor biosynthesis.

Authors:  S G Kozmin; Y I Pavlov; R L Dunn; R M Schaaper
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

4.  Inhibition of spontaneous mutagenesis by vanillin and cinnamaldehyde in Escherichia coli: Dependence on recombinational repair.

Authors:  Daniel T Shaughnessy; Roel M Schaaper; David M Umbach; David M DeMarini
Journal:  Mutat Res       Date:  2006-09-26       Impact factor: 2.433

5.  Hypoxanthine incorporation is nonmutagenic in Escherichia coli.

Authors:  Brian Budke; Andrei Kuzminov
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

6.  The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.

Authors:  Birte Plitzko; Antje Havemeyer; Thomas Kunze; Bernd Clement
Journal:  J Biol Chem       Date:  2015-02-23       Impact factor: 5.157

7.  A new reversion assay for measuring all possible base pair substitutions in Saccharomyces cerevisiae.

Authors:  Teresa-Marie Williams; Rebecca M Fabbri; Jason W Reeves; Gray F Crouse
Journal:  Genetics       Date:  2005-05-23       Impact factor: 4.562

8.  Repair system for noncanonical purines in Escherichia coli.

Authors:  Nicholas E Burgis; Jason J Brucker; Richard P Cunningham
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

9.  Elevated Levels of DNA Strand Breaks Induced by a Base Analog in the Human Cell Line with the P32T ITPA Variant.

Authors:  Irina S-R Waisertreiger; Miriam R Menezes; James Randazzo; Youri I Pavlov
Journal:  J Nucleic Acids       Date:  2010-09-26

10.  YcbX and yiiM, two novel determinants for resistance of Escherichia coli to N-hydroxylated base analogues.

Authors:  Stanislav G Kozmin; Prune Leroy; Youri I Pavlov; Roel M Schaaper
Journal:  Mol Microbiol       Date:  2008-02-26       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.